ClinicalTrials.Veeva

Menu

Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Salivary Gland Cancer
Nasopharyngeal Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT02401763
201412126RIND

Details and patient eligibility

About

Nasopharyngeal carcinoma (NPC) is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.

Full description

NPC is the tenth leading cancers in Taiwan and investigating its biomarker is important for understanding the mechanism of its pathogenesis.

Enrollment

200 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NPC and salivary gland tumor diagnosed and treated in HTUH

Exclusion criteria

  • previous treatment or surgery

Trial design

200 participants in 1 patient group

Nasopharyngeal carcinoma and salivary gland tumor
Description:
patients diagnosed and treated in National Taiwan University Hospital

Trial contacts and locations

0

Loading...

Central trial contact

Mei-Chun Lin, MD; Pei-Jen Lou, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems